Health experts notified that the United States have a severe problem regarding the Covid-19 uptake. To get rid of the most infectious disease, “Covid-19”, which is still causing a growing number of deaths, people in the US are not ready to take vaccination against the virus. Many of them, unlike other countries that have enough dose to shoot each one the individuals, however still lack behind in doing so.
A Step Towards New Vaccine: Novavax
There are several infrastructures to aid the rollout. The problem arises when not everyone is likely to take the vaccination to stay a step back from the disease. The Director of the Center for Biologics Evaluation and Research, Dr Peter Marks, stated that people of the US are going to face more significant problems in the coming days, as most individuals are not willing to take the vaccination, and we are providing every possible life saving medical care to make those people comfortable.
In USA first dose has been conducted for 48.7% of teenagers who are aged below 12, says US Centers for Disease Control and Prevention. This data shows a low vaccination percentage compared to other countries with similar vaccination intake. Moreover, in Canada, 55.5%, and in the United Kingdom, 69.6% of children below the age of 12 have been boosted.
Vaccination Hesitancy
Novavax, a new Covid-19 vaccine, was introduced on Tuesday. It was created with a Unique technique and is different from the existing three vaccines in the US. People who are allergic to the mRNA vaccine can go for this vaccine. This vaccine is made by a traditional lab method which is different in every aspect from Moderna, Pfizer/BioNTech.
The USA has been permitted to use Johnson & Johnson’s Janssen, Pfizer/BioNTech, and Moderna shot, but right now, people are going for any mRNA vaccines, which are included in three. Therefore the US is asking for a new Covid-19 dose for the people who are allergic to the mRNA doses.
